GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) » Definitions » Return-on-Tangible-Asset

Guangdong Zhongsheng Pharmaceutical Co (SZSE:002317) Return-on-Tangible-Asset : 7.22% (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Guangdong Zhongsheng Pharmaceutical Co Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Guangdong Zhongsheng Pharmaceutical Co's annualized Net Income for the quarter that ended in Mar. 2025 was ¥330 Mil. Guangdong Zhongsheng Pharmaceutical Co's average total tangible assets for the quarter that ended in Mar. 2025 was ¥4,575 Mil. Therefore, Guangdong Zhongsheng Pharmaceutical Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 was 7.22%.

The historical rank and industry rank for Guangdong Zhongsheng Pharmaceutical Co's Return-on-Tangible-Asset or its related term are showing as below:

SZSE:002317' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -11.24   Med: 8.26   Max: 16.88
Current: -5.76

During the past 13 years, Guangdong Zhongsheng Pharmaceutical Co's highest Return-on-Tangible-Asset was 16.88%. The lowest was -11.24%. And the median was 8.26%.

SZSE:002317's Return-on-Tangible-Asset is ranked worse than
70.62% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 2.68 vs SZSE:002317: -5.76

Guangdong Zhongsheng Pharmaceutical Co Return-on-Tangible-Asset Historical Data

The historical data trend for Guangdong Zhongsheng Pharmaceutical Co's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Zhongsheng Pharmaceutical Co Return-on-Tangible-Asset Chart

Guangdong Zhongsheng Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.24 6.90 7.31 5.25 -5.98

Guangdong Zhongsheng Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.99 3.03 5.41 -38.56 7.22

Competitive Comparison of Guangdong Zhongsheng Pharmaceutical Co's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Guangdong Zhongsheng Pharmaceutical Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Zhongsheng Pharmaceutical Co's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guangdong Zhongsheng Pharmaceutical Co's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Guangdong Zhongsheng Pharmaceutical Co's Return-on-Tangible-Asset falls into.


;
;

Guangdong Zhongsheng Pharmaceutical Co Return-on-Tangible-Asset Calculation

Guangdong Zhongsheng Pharmaceutical Co's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-299.157/( (5264.847+4739.135)/ 2 )
=-299.157/5001.991
=-5.98 %

Guangdong Zhongsheng Pharmaceutical Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=330.448/( (4739.135+4411.491)/ 2 )
=330.448/4575.313
=7.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2025) net income data.


Guangdong Zhongsheng Pharmaceutical Co  (SZSE:002317) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Guangdong Zhongsheng Pharmaceutical Co Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Guangdong Zhongsheng Pharmaceutical Co's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Zhongsheng Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Xihu Industrial Zone, Information Industry Park, Shilong Town, Guangdong Province, Dongguan, CHN, 523325
Guangdong Zhongsheng Pharmaceutical Co Ltd is engaged in the pharmaceutical business. It is involved in the research and development, production and sales of pharmaceuticals, the cultivation of medicinal materials, and the processing of medicinal herbs, chemical raw material synthesis, and pharmaceutical trade.
Executives
Chen Yong Hong Directors, executives
Zhao Xi Ping Executives
Zhou Xue Li Director
Zhang Yu Chong Secretary, Director
Yin Yuan Yuan Executives
Li Su Xian Supervisors
Long Chun Hua Directors, executives
Ding Chen Huan Supervisors
Li Tao Executives
Cao Jia Yue Supervisors
Zhang Shao Ri Director
Ye Hui Tang Director
Long Chao Feng Directors, executives
Sun Xian Peng Independent director
Huang Shi Bin Supervisors

Guangdong Zhongsheng Pharmaceutical Co Headlines

No Headlines